Signature Estate & Investment Advisors’s West Pharmaceutical WST Stock Holding History

Signature Estate & Investment Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$256K	Buy	+714	New	+$218K	﹤0.01%	586
2025 Q1	–	Sell	-706	Closed	-$231K	–	584
2024 Q4	$231K	Buy	706 +1	+0.1%	+$315	0.01%	474
2024 Q3	$212K	Sell	705 -32	-4%	-$9.8K	﹤0.01%	493
2024 Q2	$243K	Buy	+737	New	+$260K	0.01%	445

Other funds holding WST

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

Signature Estate & Investment Advisors's WST Position: Q2 2026 in Review

Signature Estate & Investment Advisors opened a new position in West Pharmaceutical (WST) in Q2 2026: 714 shares worth $256K. The stake represents ﹤0.01% of the portfolio and ranks #586 among its holdings. This is a return to the name: Signature Estate & Investment Advisors previously reported a position in WST as recently as Q4 2024.

Signature Estate & Investment Advisors first reported a position in WST in Q2 2024 and has held it in 4 quarters since. 386 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Signature Estate & Investment Advisors held 714 shares of West Pharmaceutical worth $256K as of Q2 2026.
West Pharmaceutical was a new Signature Estate & Investment Advisors position in Q2 2026.
West Pharmaceutical made up ﹤0.01% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #586 holding.
Signature Estate & Investment Advisors first reported a position in West Pharmaceutical in Q2 2024 and has held it in 4 quarters since.
386 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.